Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126238751 | 12623875 | 1 | I | 20150813 | 20160311 | 20160804 | 20160804 | EXP | UG-GILEAD-2016-0203435 | GILEAD | 32.00 | YR | A | F | Y | 72.00000 | KG | 20160804 | MD | UG | UG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126238751 | 12623875 | 1 | PS | EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Oral | 500 MG, QD | 003467 | 21752 | 500 | MG | TABLET | QD | |||||
| 126238751 | 12623875 | 2 | SS | EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Oral | 500 MG, QD | 004273 | 21752 | 500 | MG | TABLET | QD | |||||
| 126238751 | 12623875 | 3 | SS | RALTEGRAVIR. | RALTEGRAVIR | 1 | Unknown | 0 | |||||||||||
| 126238751 | 12623875 | 4 | SS | DARUNAVIR | DARUNAVIR | 1 | Unknown | 0 | |||||||||||
| 126238751 | 12623875 | 5 | SS | RITONAVIR. | RITONAVIR | 1 | Unknown | 0 | |||||||||||
| 126238751 | 12623875 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 126238751 | 12623875 | 7 | C | CO-AMOXICLAV /00756801/ | AMOXICILLINCLAVULANIC ACID | 1 | UNK | 0 | |||||||||||
| 126238751 | 12623875 | 8 | C | COTRIMAXAZOLE | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126238751 | 12623875 | 1 | HIV infection |
| 126238751 | 12623875 | 3 | HIV infection |
| 126238751 | 12623875 | 4 | HIV infection |
| 126238751 | 12623875 | 5 | HIV infection |
| 126238751 | 12623875 | 7 | Urinary tract infection |
| 126238751 | 12623875 | 8 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126238751 | 12623875 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126238751 | 12623875 | Abortion threatened | |
| 126238751 | 12623875 | Maternal exposure during pregnancy | |
| 126238751 | 12623875 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126238751 | 12623875 | 1 | 20141003 | 20160405 | 0 | |
| 126238751 | 12623875 | 2 | 20160406 | 0 | ||
| 126238751 | 12623875 | 7 | 20150904 | 20150909 | 0 | |
| 126238751 | 12623875 | 8 | 20080707 | 0 |